Risultati per: FDA approva un nuovo trattamento per l’emicrania

Both Cologuard Plus and Shield were approved in 2024.

The US Food and Drug Administration (FDA) approved the first at-home test for syphilis for sale without a prescription. The test, manufactured by NOWDiagnostic and called First To Know Syphilis Test, arrives amid an 80% increase in cases in the US between 2018 and 2022, from 115 000 to 207 000 cases.

The US Food and Drug Administration (FDA) recently approved neffy, an epinephrine nasal spray, to treat emergency allergic reactions, including anaphylaxis. The spray is the first alternative treatment to epinephrine injections for adults and children who weigh at least 30 kg, or about 66 lb.

This Viewpoint analyzes the Psychopharmacologic Drugs Advisory Committee’s decisions regarding 3,4-methylenedioxymethamphetamine–assisted therapy and what they mean for psychedelic research.

Analisi su British Medical Journal,tuttavia sono sottoutilizzati

Bene lo studio di fase III

‘In molti casi otteniamo la guarigione, ma la prevenzione è fondamentale’

Il via libera dopo l’esame di 38 dossier

New England Journal of Medicine, Ahead of Print.

This Medical News story examines the controversy surrounding the FDA’s first authorization of flavored e-cigarettes, in this case menthol.

In this Viewpoint, the authors refute recent suggestions that the US Food and Drug Administration (FDA) is not accountable for its decisions, pointing out the legal, legislative, and executive checks and balances on the agency.